Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus

NCT01126255 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

37

Enrollment

OTHER

Sponsor class

Stopped Recruitment problems

Conditions

Vulvar Lichen Sclerosus

Interventions

DRUG: Clobetasol propionate 0.05%
DRUG: Progesterone 8%

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]